Increased uric acid and glucose concentrations in vitreous and serum of patients with diabetic macular oedema

Ophthalmic Research

Volumn 46, Issue 2, 2011, Pages 73-79

  Krizova, Libuse ^a   Kalousova, Marta ^a   Kubena, Ales ^b   Benakova, Hana ^a   Zima, Tomas ^a,c   Kovarik, Zdenek ^a   Kalvoda, Jan ^a   Kalvodova, Bohdana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Diabetic macular oedema; Diabetic retinopathy; Glucose; Uric acid; Vitreous

Indexed keywords

GLUCOSE; URIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROSPECTIVE STUDY; URIC ACID BLOOD LEVEL; VITRECTOMY; VITREOUS BODY;

AGED; BLOOD GLUCOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URIC ACID; VITREOUS BODY;

EID: 78651385712     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000322994     Document Type: Article

References (25)

1. Sheetz MJ, King GL: Molecular understanding of hyperglycaemia's adverse effects for diabetic complications. JAMA 2002; 228: 2579-2588. (Pubitemid 35386893)
2. Gardner TW, Antonetti DA, Barber AJ, La Noue KF, Levison SW: Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2002; 47:S253-S262. (Pubitemid 36351245)
3. Engler C, Krogsaa B, Lund-Andersen H: Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. Graefe's Arch Clin Exp Ophthalmol 1991; 229: 442-446.
4. Huang EJ, Kuo WW, Chen YJ, Chen TH, Chang MH, Lu MC, Tzang BS, Hsu HH, Huang CY, Lee SD: Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. Clin Chim Acta 2006; 366: 293-298.
5. Kroll P, Büchele Rodrigues E, Hoerle S: Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica 2007; 221: 78-94. (Pubitemid 46465433)
6. Aiello LP, Cahill MT, Wong JS: Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol 2001; 132: 760-776. (Pubitemid 33031293)
7. Castillo A, Del Castillo JMB, Diaz D, Sayagues O, Rubal JL, Garcia-Sanchez J: Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics: a 4-year follow-up study. Graefe's Arch Clin Exp Ophthalmol 1996; 234: 246-250. (Pubitemid 26097965)
8. Porta M, Sjoelie AK, Chaturvedi N, Stevens L, Rottiers R, Veglio M, Fuller JH, EURODIAB Prospective Complications Study Group: Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 2001; 44: 2203-2209. (Pubitemid 34015473)
9. Zhang L, Krzentowski G, Albert A, Lefebvre PJ: Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001; 24: 1275-1279. (Pubitemid 33716411)
10. Klein R, Klein BE, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105: 1801-1815. (Pubitemid 28509717)
11. UK Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 1998; 317: 703-712.
12. Chew EY: Diabetic retinopathy and lipid abnormalities. Curr Opin Ophthalmol 1997; 8: 59-62. (Pubitemid 27344621)
13. Olivarius N, Nielsen N, Andersen A: Diabetic retinopathy in newly diagnosed middleaged and elderly patients: prevalence and interrelationship with microalbuminuria and triglycerides. Graefe's Arch Clin Exp Ophthalmol 2001; 239: 664-672. (Pubitemid 32927015)
14. Ciulla TA, Amador AG, Zinman B: Diabetic retinopathy and diabetic macular edema: pathophysiology, screening and novel therapies. Diabetes Care 2003; 26: 2653-2664. (Pubitemid 37055447)
15. Kowluru RA, Chan P-S: Oxidative stress and diabetic retinopathy. Exp Diabetes Res DOI: 10.1155/2007/43603.
16. Liter LA: The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering? Diabetes Res Clin Pract 2005; 68:S3-S14.
17. Ioachimescu AG, Brennant DM, Hoart BM, Kashyap SR, Hoogwerf BJ: Serum uric acid, mortality and glucose control in patients with type 2 diabetes mellitus: a PreCIS database study. Diabet Med 2007; 24: 1369-1374. (Pubitemid 350179450)
18. Hayden MR, Tyagi SC: Uric acid - a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab DOI: 10.1186/1743-7075-1-10.
19. Zoccali C, Maio R, Mallamaci F, Sesti G, Pericone F: Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 2006; 17: 1466-1471. (Pubitemid 43673429)
20. García-Ramírez M, Canals F, Hernandéz C, Colomé N, Ferrer C, Carrasco E, García-Arumí J, Simó R: Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia 2007; 50: 1249-1303.
21. WHO Study Group: Diabetes mellitus: report of a WHO study group. World Health Organ Tech Rep Ser 1985; 727: 1-113.
22. Early Treatment Diabetic Retinopathy Study Research Group: Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report No 12. Ophthalmology 1991; 98: 823-33.
23. Johnson RJ, Kang DH, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M: Is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190. (Pubitemid 36706063)
24. Yokoi M, Yamagishi S-I, Takeuchi M, Ohgami K, Okamoto T, Saito W, Muramatsu M, Imazumi T, Ohno S: Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy. Br J Ophthalmol 2005; 89: 673-675. (Pubitemid 40780571)
25. Marumo T, Noll T, Schini-Kerth VB, Harley EA, Duhault J, Piper HM, Busse R: Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor. J Vasc Res 1999; 36: 510-515. (Pubitemid 30020056)